Search

everythinglearnresearchcommunity

for

Search:↓

Different types of stem cells exist within individual skin layers, and they can adapt to damage, transplantation, or tumor growth. These cells are regulated by their environment and genetic factors. Tumor growth is driven by expanding, genetically altered cells, not long-lived mutant stem cells. There's evidence of cancer stem cells in skin tumors. Other cells, bacteria, and genetic factors help maintain balance and contribute to disease progression. A method for growing mini organs from single cells has been developed.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Recombinant human epidermal growth factor is versatile, effective, and safe for long-term skin and mucosal treatments.

Histone demethylases play a key role in the development of many diseases and may be targets for treatment.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Cells with active Wnt signaling are less likely to turn into cancer when exposed to a cancer-causing gene.

sPLA2-IIA increases growth in hair follicle stem cells and cancer cells, suggesting it could be targeted for hair growth and cancer treatment.

The p53 protein has complex, sometimes contradictory functions, including tumor suppression and promoting cell survival.

Wnt signaling may be linked to heart diseases in aging and could be a target for future treatments.

MicroRNAs play a crucial role in skin and hair health, affecting everything from growth to aging, and could potentially be used in treating skin diseases.

New treatments for skin conditions related to the sebaceous gland are being developed based on current research.

Deleting Smad4 and PTEN genes in mice causes rapid, invasive stomach cancer.

Deleting Smad4 and PTEN genes in mice causes rapid, invasive forestomach cancer.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

Metformin, a diabetes drug, may also help fight cancer, but more research is needed to understand how.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

The study found that genetic differences related to hair growth and other traits help cashmere goats adapt to high-altitude environments.

Metformin, a diabetes drug, may help prevent and treat various cancers, but more research is needed.

Most drugs fail to reach the market, but understanding their properties and using strategies like early toxicity tests and drug repurposing can help advance their development.

The conclusion is that proper signaling is crucial for hair growth and development, and errors can lead to cancer or hair loss.

The document concludes that mouse models are crucial for studying hair biology and that all mutant mice may have hair growth abnormalities that require detailed analysis to identify.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

The treatment was ineffective in humans.

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.

Genomic approach finds new possible treatments for hair loss.

Deleting the Trf1 protein in mice is safe and may help prevent cancer without major side effects.

RNA delivery is best for in-body use, while RNP delivery is good for outside-body use. Both methods are expected to greatly impact future treatments.

High-dose finasteride may help treat glioblastoma but needs localized delivery for effectiveness.